BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20362790)

  • 1. Curative radiation therapy for pancreatic malignancies.
    Cooke EW; Hazard L
    Surg Clin North Am; 2010 Apr; 90(2):341-54. PubMed ID: 20362790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant and neoadjuvant therapy in curable pancreatic cancer.
    Nugent FW; Stuart K
    Surg Clin North Am; 2010 Apr; 90(2):323-39. PubMed ID: 20362789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas.
    Kachnic LA; Shaw JE; Manning MA; Lauve AD; Neifeld JP
    Int J Cancer; 2001 Apr; 96(2):132-9. PubMed ID: 11291097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant treatment of pancreatic cancer].
    Oettle H
    Zentralbl Chir; 2003 May; 128(5):411-8. PubMed ID: 12813641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radically resected pancreatic cancer and adjuvant treatment. A review of the literature].
    Drudi F; Tassinari D; Giuliani J; Ridolfi C; Gianni L; Tamburini E; Fantini M; Santelmo C; Barzotti E; Lotti N; Ravaioli A
    Recenti Prog Med; 2013 Feb; 104(2):80-5. PubMed ID: 23535964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
    Allen AM; Zalupski MM; Robertson JM; Eckhauser FE; Simone D; Brown D; Hejna G; Normolle D; Lawrence TS; McGinn CJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1461-7. PubMed ID: 15275733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
    Small W; Berlin J; Freedman GM; Lawrence T; Talamonti MS; Mulcahy MF; Chakravarthy AB; Konski AA; Zalupski MM; Philip PA; Kinsella TJ; Merchant NB; Hoffman JP; Benson AB; Nicol S; Xu RM; Gill JF; McGinn CJ
    J Clin Oncol; 2008 Feb; 26(6):942-7. PubMed ID: 18281668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.
    Ben-Josef E; Shields AF; Vaishampayan U; Vaitkevicius V; El-Rayes BF; McDermott P; Burmeister J; Bossenberger T; Philip PA
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):454-9. PubMed ID: 15145162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study.
    Van Laethem JL; Demols A; Gay F; Closon MT; Collette M; Polus M; Houbiers G; Gastelblum P; Gelin M; Houtte PV; Closset J
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):974-80. PubMed ID: 12829132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes in patients with early stage, resected pancreatic cancer - a comparison of gemcitabine- and 5-fluorouracil-based chemotherapy and chemoradiation regimens.
    Kizilbash SH; Ward KC; Liang JJ; Jaiyesimi I; Lipscomb J
    Int J Clin Pract; 2014 May; 68(5):578-89. PubMed ID: 24472057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of different treatment methods on survival in advanced pancreatic cancer.
    Brasiūniene B; Juozaityte E; Barauskas G
    Medicina (Kaunas); 2005; 41(5):382-5. PubMed ID: 15947521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiation protocols offer only incremental gains for pancreatic cancer patients.
    Bankhead C
    J Natl Cancer Inst; 2002 Nov; 94(22):1670-2. PubMed ID: 12441320
    [No Abstract]   [Full Text] [Related]  

  • 14. [Radiation therapy in pancreatic cancer].
    Chie EK
    Korean J Gastroenterol; 2008 Feb; 51(2):101-10. PubMed ID: 18349572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of combined treatment methods on survival and toxicity in patients with pancreatic cancer.
    Brasiūniene B; Juozaityte E
    Medicina (Kaunas); 2007; 43(9):716-25. PubMed ID: 17986845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
    Regine WF; Winter KA; Abrams RA; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Kudrimoti MR; Fromm ML; Haddock MG; Schaefer P; Willett CG; Rich TA
    JAMA; 2008 Mar; 299(9):1019-26. PubMed ID: 18319412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adjuvant and additive therapy for cancer of the pancreas].
    Neoptolemos JP; Raraty MG; Ghaneh P; Hickey H; Stocken DD; Dunn JA; Friess H; Büchler MW
    Chirurg; 2003 Mar; 74(3):191-201. PubMed ID: 12647075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
    Wilkowski R; Thoma M; Heinemann V; Rau HG; Wagner A; Stoffregen C; Dühmke E
    Strahlenther Onkol; 2003 Feb; 179(2):78-86. PubMed ID: 12590317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of adjuvant therapy for pancreatic cancer.
    Katz MH; Fleming JB; Lee JE; Pisters PW
    Oncologist; 2010; 15(11):1205-13. PubMed ID: 21045189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer.
    Park JK; Ryu JK; Lee JK; Yoon WJ; Lee SH; Kim YT; Yoon YB
    Pancreas; 2006 Nov; 33(4):397-402. PubMed ID: 17079946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.